Wordt geladen...
Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature
Bevacizumab, an angiogenesis inhibitor, is a recombined humanized monoclonal antibody against vascular endothelial growth factor and a promising therapeutic option for angiosarcoma management. This is a case report and review of the literature using bevacizumab and combination chemotherapy for angio...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3696716/ https://ncbi.nlm.nih.gov/pubmed/23825914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2013.06.09 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|